Dermata Therapeutics, Inc. (DRMA)
0.8699
+0.01
(+1.16%)
USD |
NASDAQ |
Oct 20, 16:00
0.85
-0.02
(-2.29%)
After-Hours: 06:03
Dermata Therapeutics Shareholders Equity (Quarterly) : 3.488M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 3.488M |
| March 31, 2026 | 6.413M |
| December 31, 2025 | 6.223M |
| September 30, 2025 | 3.960M |
| June 30, 2025 | 5.614M |
| March 31, 2025 | 7.301M |
| December 31, 2024 | 1.561M |
| September 30, 2024 | 4.741M |
| June 30, 2024 | 3.318M |
| March 31, 2024 | 3.808M |
| December 31, 2023 | 6.355M |
| Date | Value |
|---|---|
| September 30, 2023 | 6.407M |
| June 30, 2023 | 8.03M |
| March 31, 2023 | 8.088M |
| December 31, 2022 | 6.022M |
| September 30, 2022 | 7.471M |
| June 30, 2022 | 9.66M |
| March 31, 2022 | 7.852M |
| December 31, 2021 | 10.11M |
| September 30, 2021 | 12.49M |
| June 30, 2021 | -0.5058M |
| March 31, 2021 | 0.712M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Anika Therapeutics, Inc. | 137.28M |
| Perspective Therapeutics, Inc. | 323.86M |
| MiMedx Group, Inc. | 216.00M |
| ABVC BioPharma, Inc. | 10.29M |
| Agilent Technologies, Inc. | 7.363B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 5.321M |
| Total Liabilities (Quarterly) | 1.833M |
| Current Ratio | 2.803 |